BioSpace News Archive

Business

Satsuma Pharmaceuticals Reports First Quarter 2021 Financial Results and Recent Business Highlights

Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA), a clinical-stage biopharmaceutical company developing STS101, a novel therapeutic product candidate for the acute treatment of migraine, today reported financial results for the first quarter of 2021 and summarized recent business highlights.

May 11, 2021
·
8 min read
Business

Sientra Reports Record First Quarter 2021 Financial Results

Sientra, Inc., a medical aesthetics company uniquely focused on plastic surgeons, announced its financial results for the first quarter ended March 31, 2021.

May 11, 2021
·
13 min read
Business

Iridex Announces First Quarter 2021 Financial Results

We enjoyed a strong start to 2021 and our positive momentum continued with revenue that exceeded pre-COVID levels, setting a record for first quarter revenue.

May 11, 2021
·
6 min read
Business

Olema Oncology Reports First Quarter 2021 Financial Results and Provides Corporate Update

OP-1250 continues to advance in dose-escalation stage of Phase 1/2 clinical trial in patients with metastatic, ER+ / HER2- breast cancer; Initial data anticipated in 2H 2021

May 11, 2021
·
6 min read
Biotech Beach

Neurocrine Biosciences to Present at the 2021 RBC Global Healthcare Conference

Neurocrine Biosciences, Inc. will present at the 2021 RBC Capital Markets Healthcare Conference at 10:55 a.m. Eastern Time on Tuesday May 18, 2021.

May 11, 2021
·
1 min read
Lone Star Bio

Caris Life Sciences Raises $830 Million in Growth Equity Capital to Continue to Expand its Precision Medicine Platform

Caris Life Sciences®, a leading innovator in molecular science and artificial intelligence (AI) focused on fulfilling the promise of precision medicine, announced an $830 million growth equity round at a post-money valuation of $7.83 billion.

May 11, 2021
·
6 min read
Business

Aridis Pharmaceuticals Announces First Quarter 2021 Results

Aridis Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening infections, reported financial and corporate results for the first quarter ended March 31, 2021.

May 11, 2021
·
15 min read
Genetown

Brooks to Participate in the 16th Annual Needham Virtual Technology & Media Conference

Brooks Automation, Inc. announced that company management will participate in the 16th Annual Needham Virtual Technology & Media Conference on Thursday, May 20, 2021 which includes a webcast beginning at 11:00 a.m. ET.

May 11, 2021
·
2 min read
Business

Poseida Therapeutics Reports Program Updates and Financial Results for the First Quarter 2021

Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the capacity to cure, announced program updates and financial results for the first quarter ended March 31, 2021.

May 11, 2021
·
9 min read
Business

Cumberland Pharmaceuticals Reports First Quarter 2021 Financial Results & Company Update

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, is providing a company update and first quarter 2021 financial results.

May 11, 2021
·
19 min read